Hall Laurie J Trustee Myriad Genetics Inc Transaction History

Hall Laurie J Trustee

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$11.25 - $14.75 $2,250 - $2,950	-200 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$20.93 - $35.1 $837 - $1,404	40 Added 25.0%	200 $5,000
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $1,089 - $1,822	-40 Reduced 20.0%	160 $5,000
Q4 2017 Jan 30, 2018	SELL	$28.45 - $37.14 $2,845 - $3,714	-100 Reduced 33.33%	200 $7,000
Q2 2017 Aug 22, 2017	BUY	N/A	300	300 $0

228

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $807M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.